Search research articles
Contact Us
Filters
Showing results (61-70 of 63) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 63 results.
British Journal of Clinical Pharmacology
|
April 8, 2026
Sequential nephron blockade vs. sequential renin-angiotensin system blockade on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial
Juan Carlos Yugar-Toledo, Tatiana Palotta Minari, Priscilla Galisteu de Mello, et al.
British Journal of Clinical Pharmacology
|
August 27, 2025
Effects of different antihypertensive drug classes on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial
Juan Carlos Yugar-Toledo, Tatiana Palotta Minari, Priscilla Galisteu de Mello, et al.
Arquivos Brasileiros De Cardiologia
|
December 17, 2020
Evaluation of 1-Year Follow-up of Patients Included in the Registry of Clinical Practice in Patients at High Cardiovascular Risk (REACT)
Pedro Gabriel Melo de Barros E Silva, Otavio Berwanger, Dalton Bertolim Precoma, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 63) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 63 results.
British Journal of Clinical Pharmacology
|
April 8, 2026
Sequential nephron blockade vs. sequential renin-angiotensin system blockade on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial
Juan Carlos Yugar-Toledo, Tatiana Palotta Minari, Priscilla Galisteu de Mello, et al.
British Journal of Clinical Pharmacology
|
August 27, 2025
Effects of different antihypertensive drug classes on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial
Juan Carlos Yugar-Toledo, Tatiana Palotta Minari, Priscilla Galisteu de Mello, et al.
Arquivos Brasileiros De Cardiologia
|
December 17, 2020
Evaluation of 1-Year Follow-up of Patients Included in the Registry of Clinical Practice in Patients at High Cardiovascular Risk (REACT)
Pedro Gabriel Melo de Barros E Silva, Otavio Berwanger, Dalton Bertolim Precoma, et al.
Page
of 7